Publication | Closed Access
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy
123
Citations
34
References
2001
Year
Hematological MalignancyOncologyBcr-abl-expressing Leukemia CellsMedicineHsp90 Inhibitor GeldanamycinAnti-cancer AgentPharmacologyCell BiologyCancer ResearchTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1